Pfizer, BioNTech Choose Coronavirus Vaccine Candidate to Advance to Phase 2/3 TrialThe Motley Fool • 07/28/20
Fauci: Coronavirus Vaccine Likely Not "Widely Available" Until Several Months Into 2021The Motley Fool • 07/24/20
Pfizer and BioNTech Ink Deal with U.S. Government for Big Coronavirus Vaccine PurchaseThe Motley Fool • 07/22/20